0
ARTICLE |

Urine Calcitonin Levels in Patients With Bronchogenic Carcinoma FREE

Kenneth L. Becker, MD, PhD; Donald R. Nash, PhD; Omega L. Silva, MD; Richard H. Snider, PhD; Charles F. Moore
[+] Author Affiliations

Reprint requests to Metabolic Research, Veterans Administration Medical Center, 50 Irving St NW, Washington, DC 20422 (Dr Becker).


JAMA. 1980;243(7):670-672. doi:10.1001/jama.1980.03300330028025
Text Size: A A A
Published online

We demonstrated previously that high serum calcitonin values in bronchogenic carcinoma are useful clinically as a parameter of progress of the disease and response to therapy. After developing a procedure for the measurement of calcitonin in urine, we studied serum and urine levels in 41 patients with lung cancer, using both a carboxyl terminus and a midportion recognizing antiserum. In general, midportion antiserum was more useful. Urine calcitonin measurements alone were superior to serum in terms of numbers of patients having increased values with one or both antisera (76% vs 46%). When both antisera were used to assay both serum and urine, 90% of patients had abnormal values. Once a tissue diagnosis has been established, the radioimmunoassay of urinary calcitonin offers a new dimension to the utility of this hormone as a marker for bronchogenic carcinoma.

(JAMA 243:670-672, 1980)

REFERENCES

Silva OL, Becker KL, Primack A, et al:  Increased serum calcitonin in bronchogenic cancer . Chest 69:495-499, 1976;.
Becker KL, Snider RH, Silva OL, et al:  Calcitonin heterogeneity in lung cancer and medullary thyroid cancer . Acta Endocrinol 89:89-99, 1978;.
Silva OL, Becker KL, Primack A, et al:  Ectopic secretion of calcitonin in oat cell carcinoma . N Engl J Med 290:1122-1124, 1974;.
Silva OL, Becker KL, Primack A, et al:  Hypercalcitonemia in bronchogenic cancer: Evidence for thyroid origin of the hormone . JAMA 234:183-185, 1975;.
Silva OL, Snider RH, Moore CF, et al:  Urine calcitonin as a test for medullary thyroid cancer . Ann Surg 189:269-274, 1979;.
Silva OL, Snider RH, Becker KL:  Radioimmunoassay of human calcitonin in human plasma . Clin Chem 20:337-339, 1974;.
Snider RH, Silva OL, Moore CF, et al:  Immunochemical heterogeneity of calcitonin in man: Effect on radioimmunoassay . Clin Chim Acta 76:1-14, 1977;.
Snider RH, Moore CF, Silva OL, et al:  Radioimmunoassay of calcitonin in the urine of normal man . Anal Chem 50:449-454, 1978;.
Silva OL, Broder LE, Doppman JL, et al:  Calcitonin as a marker for bronchogenic cancer: A prospective study . Cancer 44:334-338, 1979;.
Silva OL, Becker KL:  Calcitonin as a marker for cancer , in Rudden RW (ed): Biological Markers of Neoplasia: Basic and Applied Aspects . Amsterdam, Elsevier North Holland Inc, 1978;, pp 295-310.
Silva OL, Becker KL, Shalhoub RJ, et al:  Calcitonin levels in chronic renal disease . Nephron 19:12-18, 1977;.
Heynen G, Franchimont P:  Human calcitonin radioimmunoassay in normal and pathological conditions . Eur J Clin Invest 4:213-222, 1974;.
Sizemore G, Go VL, Kaplan EL, et al:  Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid . N Engl J Med 288:641-644, 1973;.
Tashjian AH Jr, Voelkel EF, Wolfe HJ, et al:  Calcitonin and prostaglandins: Significance, relevance, and uncertainties , in Talmage RV, Owen M, Parsons JA (eds): Calcium Regulating Hormones . Amsterdam, Excerpta Medica, 1975;, pp 135-148.
Samaan NA, Anderson GD, Adam-Mayne ME:  Immunoreactive calcitonin in the mother, neonate, child, and adult . Am J Obstet Gynecol 121:622-625, 1975;.
Becker KL, Nash DR, Silva OL, et al:  Increased calcitonin in lung disease . Clin Res , to be published.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Silva OL, Becker KL, Primack A, et al:  Increased serum calcitonin in bronchogenic cancer . Chest 69:495-499, 1976;.
Becker KL, Snider RH, Silva OL, et al:  Calcitonin heterogeneity in lung cancer and medullary thyroid cancer . Acta Endocrinol 89:89-99, 1978;.
Silva OL, Becker KL, Primack A, et al:  Ectopic secretion of calcitonin in oat cell carcinoma . N Engl J Med 290:1122-1124, 1974;.
Silva OL, Becker KL, Primack A, et al:  Hypercalcitonemia in bronchogenic cancer: Evidence for thyroid origin of the hormone . JAMA 234:183-185, 1975;.
Silva OL, Snider RH, Moore CF, et al:  Urine calcitonin as a test for medullary thyroid cancer . Ann Surg 189:269-274, 1979;.
Silva OL, Snider RH, Becker KL:  Radioimmunoassay of human calcitonin in human plasma . Clin Chem 20:337-339, 1974;.
Snider RH, Silva OL, Moore CF, et al:  Immunochemical heterogeneity of calcitonin in man: Effect on radioimmunoassay . Clin Chim Acta 76:1-14, 1977;.
Snider RH, Moore CF, Silva OL, et al:  Radioimmunoassay of calcitonin in the urine of normal man . Anal Chem 50:449-454, 1978;.
Silva OL, Broder LE, Doppman JL, et al:  Calcitonin as a marker for bronchogenic cancer: A prospective study . Cancer 44:334-338, 1979;.
Silva OL, Becker KL:  Calcitonin as a marker for cancer , in Rudden RW (ed): Biological Markers of Neoplasia: Basic and Applied Aspects . Amsterdam, Elsevier North Holland Inc, 1978;, pp 295-310.
Silva OL, Becker KL, Shalhoub RJ, et al:  Calcitonin levels in chronic renal disease . Nephron 19:12-18, 1977;.
Heynen G, Franchimont P:  Human calcitonin radioimmunoassay in normal and pathological conditions . Eur J Clin Invest 4:213-222, 1974;.
Sizemore G, Go VL, Kaplan EL, et al:  Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid . N Engl J Med 288:641-644, 1973;.
Tashjian AH Jr, Voelkel EF, Wolfe HJ, et al:  Calcitonin and prostaglandins: Significance, relevance, and uncertainties , in Talmage RV, Owen M, Parsons JA (eds): Calcium Regulating Hormones . Amsterdam, Excerpta Medica, 1975;, pp 135-148.
Samaan NA, Anderson GD, Adam-Mayne ME:  Immunoreactive calcitonin in the mother, neonate, child, and adult . Am J Obstet Gynecol 121:622-625, 1975;.
Becker KL, Nash DR, Silva OL, et al:  Increased calcitonin in lung disease . Clin Res , to be published.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.